Age-related macular degeneration (AMD) is the leading cause of blindness among the
elderly in developed countries. AMD is classified as either neovascular (NV-AMD) or non …

Human pluripotent stem cells are known to have the capacity to renew indefinitely, being
intrinsically able to differentiate into many different cell types. These characteristics have …

The field of stem cell therapeutics is moving ever closer to widespread application in the
clinic. However, despite the undoubted potential held by these therapies, the balance …

Human embryonic stem cells (hESC) have emerged as attractive candidates for cell-based
therapies that are capable of restoring lost cell and tissue function. These unique cells are …

The discovery of induced pluripotent stem cells (iPSCs) and concurrent development of
protocols for their cell-type specific differentiation have revolutionized studies of diseases …

Human pluripotent stem cells (hPSCs) have practically unlimited proliferation potential and a
capability to differentiate into any cell type in the human body. Since the first derivation in …

Background Mesenchymal stromal cells (MSC) may serve as an attractive therapy in renal
transplantation due to their immunosuppressive and reparative properties. While most …

Medical research in regenerative medicine and cell-based therapy has brought encouraging
perspectives for the use of stem cells in clinical trials. Multiple types of stem cells, from …

Both human pluripotent stem cells (hPSCs) from embryonic stem cells (hESCs) and induced
pluripotent stem cells (hiPSCs) have the potential ability to differentiate into many different …

The application of human embryonic stem cell (hESC) derivatives to regenerative medicine
is now becoming a reality. Although the vast majority of hESC lines have been derived for …